Abstract
Platelet reactivity (PR) testing has prognostic value in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). There are conflicting data on the optimal type and timing of PR testing. We investigated the prognostic value of high on-aspirin PR (ASPR) and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have